Daxor Corporation Market Cap ($50.70 Million)
Market Cap & Net Worth: Daxor Corporation (DXR)
Daxor Corporation market cap. Daxor Corporation (NASDAQ:DXR) has a market capitalization of $50.70 Million ($50.70 Million) as of November 4, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #21647 globally and #4848 in its home market, demonstrating a -5.54% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Daxor Corporation's stock price $8.70 by its total outstanding shares 5827225 (5.83 Million). Also see how efficiently does Daxor Corporation generate cash for how efficiently the company converts equity into cash flow.
Daxor Corporation Market Cap History (2015–2026)
Daxor Corporation market cap history from 2015 to 2026. Data shows change from $43.54 Million to $50.70 Million (-0.01% CAGR). Check DXR share price today for real-time trading data and today's change.
Daxor Corporation Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Daxor Corporation's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Daxor Corporation annual equity growth to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
21.03x
Daxor Corporation's market cap is 21.03 times its annual revenue
Latest Price to Earnings (P/E) Ratio
83.55x
Daxor Corporation's market cap is 83.55 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $43.54 Million | $-7.44 Million | -$9.15 Million | -5.85x | N/A |
| 2016 | $47.39 Million | $1.84 Million | $1.46 Million | 25.82x | 32.55x |
| 2017 | $26.46 Million | $-1.01 Million | -$1.24 Million | -26.16x | N/A |
| 2018 | $47.78 Million | $-918.45K | -$885.77K | -52.03x | N/A |
| 2019 | $54.78 Million | $-114.99K | -$495.70K | -476.35x | N/A |
| 2020 | $72.84 Million | $-996.30K | -$1.71 Million | -73.11x | N/A |
| 2021 | $65.76 Million | $5.82 Million | $4.75 Million | 11.30x | 13.85x |
| 2022 | $53.38 Million | $6.31 Million | $5.18 Million | 8.46x | 10.31x |
| 2023 | $55.94 Million | $34.59 Million | $280.64K | 1.62x | 199.33x |
| 2024 | $44.81 Million | $2.13 Million | $536.33K | 21.03x | 83.55x |
Competitor Companies of DXR by Market Capitalization
Companies near Daxor Corporation in the global market cap rankings as of November 4, 2026. Also see Daxor Corporation (DXR) total assets for a full breakdown of the balance sheet.
Key companies related to Daxor Corporation by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #175 globally with a market cap of $132.26 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #258 globally with a market cap of $99.74 Billion USD ( €85.32 Billion EUR).
- ESSILORLUXOTTICA 1/2/O.N. (F:ESLC): Ranked #418 globally with a market cap of $67.43 Billion USD ( €57.68 Billion EUR).
- HOYA CORP. ADR/ 1 O.N. (F:HYB0): Ranked #535 globally with a market cap of $50.37 Billion USD ( €43.09 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #175 | Intuitive Surgical Inc | NASDAQ:ISRG | $132.26 Billion | $440.75 |
| #258 | EssilorLuxottica S. A. | PA:EL | $99.74 Billion | €184.25 |
| #418 | ESSILORLUXOTTICA 1/2/O.N. | F:ESLC | $67.43 Billion | €91.50 |
| #535 | HOYA CORP. ADR/ 1 O.N. | F:HYB0 | $50.37 Billion | €150.00 |
Market Capitalization of Daxor Corporation (2015–2026)
Market capitalization of Daxor Corporation from 2015 to today. Between 2015 and today, Daxor Corporation's market cap moved from $43.54 Million to $ 50.70 Million, with a yearly change of -0.01%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $50.70 Million | -41.02% |
| 2025 | $85.95 Million | +91.81% |
| 2024 | $44.81 Million | -19.90% |
| 2023 | $55.94 Million | +4.80% |
| 2022 | $53.38 Million | -18.83% |
| 2021 | $65.76 Million | -9.72% |
| 2020 | $72.84 Million | +32.98% |
| 2019 | $54.78 Million | +14.63% |
| 2018 | $47.78 Million | +80.59% |
| 2017 | $26.46 Million | -44.17% |
| 2016 | $47.39 Million | +8.84% |
| 2015 | $43.54 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Daxor Corporation was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $50.70 Million USD |
| MoneyControl | $50.70 Million USD |
| MarketWatch | $50.70 Million USD |
| marketcap.company | $50.70 Million USD |
| Reuters | $50.70 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Daxor Corporation
Daxor Corporation engages in medical instrumentation and biotechnology operations. It develops the BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume, in conjunction with Volumex, a single-use radiopharmaceutical diagnostic injection and collection kit. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corpo… Read more